×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
💹
Economics
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Economics
Status
Showcase
▼
Showcase
Demo
Vision
|
Showcase
←
Home
/
Artifacts
/
Enteric Neurons in Parkinson's Disease
📖
Enteric Neurons in Parkinson's Disease
wiki page
Created: 2026-04-02T13:40:08
By: crosslink-migration
Quality:
50%
✓ SciDEX
ID: wiki-cell-types-enteric-neurons-in-parki
Related Entities
cell-types-enteric-neurons-in-parkinsons-disease
Linked Artifacts (180)
related
🧫
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
70%
related
🧫
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
70%
related
🧫
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
60%
related
🧫
Peroxisomal Dysfunction Validation in Parkinson's Disea
60%
related
🧫
DNA Damage Repair Deficiency Validation Study in Parkinson
60%
related
🧫
Endocannabinoid System Dysfunction Validation in Parkinson
60%
related
🧫
Stress Granule Dysfunction Validation in Parkinson's Di
60%
related
🧫
Regulated Necrosis Validation Study in Parkinson's Dise
60%
related
🧫
Combination Therapy Sequencing in Parkinson's Disease
60%
related
🧫
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson
60%
related
🧫
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
60%
related
🧫
Prodromal Parkinson's Disease Biomarker Development — E
60%
related
🧫
MLCS Quantification in Parkinson's Disease
60%
related
🧫
Peroxisome Dysfunction Validation in Parkinson's Diseas
60%
related
🧫
CRISPR Gene Correction Approaches for CBS/PSP
60%
related
🧫
Axonal Transport Dysfunction Validation in Parkinson's
60%
related
🧫
Purinergic Signaling Dysfunction Validation in Parkinson
60%
related
🧫
Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
60%
related
🧫
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
60%
related
🧫
Alpha-Synuclein Seed Amplification Assay Validation
60%
related
🧫
Synaptic Vesicle Trafficking Dysfunction Validation in Parki
60%
related
🧫
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
60%
related
🧫
Sirtuin Dysfunction Validation in Parkinson's Disease
60%
related
🧫
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
60%
related
🧫
Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in
60%
related
🧫
Experiment: Multi-Ethnic PD GWAS
60%
related
🧫
Neural Oscillation Dysfunction Validation in Parkinson'
60%
see_also
📖
PIEZO1 — Piezo Type Mechanosensitive Ion Channel Component 1
60%
related
🧫
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
60%
related
🧫
Epigenetic Dysregulation Validation in Parkinson's Dise
60%
related
🧫
Cytochrome Therapeutics
60%
related
🧫
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
60%
related
🧫
cGAS-STING Pathway Validation Study in Parkinson's Dise
60%
related
🧫
Sirtuin Pathway Dysfunction Validation in Parkinson's D
60%
related
🧫
TREM2 Agonist Therapy for Parkinson's Disease — Experim
60%
related
🧫
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
60%
related
🧫
Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr
60%
related
🧫
AAV-LRRK2 IND-Enabling Study Design
60%
related
🧫
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
60%
related
🧫
Parkinson's Disease Subtype Classification — Precision
60%
related
🧫
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
60%
related
🧫
Exercise-BDNF-Mitophagy Biomarker Study in PD
60%
related
🧫
Antiviral Therapy Trial for Parkinson's Disease
60%
related
🧫
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&
60%
related
🧫
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
60%
related
🧫
Non-Motor Symptom Progression in Parkinson's Disease —
60%
related
🧫
Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper
60%
related
🧫
Validate Mitochondria-Lysosome Contact Site Dysfunction in P
60%
related
🧫
Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me
60%
related
🧫
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&
60%
related
🧫
Synaptic Mitochondrial Resilience Enhancement for Parkinson&
60%
related
🧫
Macroautophagy Dysfunction in PD - Experiment Design
60%
related
🧫
Ferroptosis Validation in Parkinson's Disease
60%
related
🧫
AAV Serotype Comparison for LRRK2 Knockdown in PD
60%
related
🧫
Multiscale Computational Modeling of Protein Aggregation Kin
60%
related
🧫
NLRP3 Inflammasome Validation Study in Parkinson's Dise
60%
related
🧫
GLP-1 Agonist Neuroprotection Mechanism in PD
60%
related
🧫
Computational Modeling of Alpha-Synuclein Propagation in PD
60%
related
🧫
Validation: Membrane-Nucleation in iPSC Neurons
60%
related
🧫
Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
60%
related
🧫
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
60%
related
🧫
Sirtuin Pathway Dysfunction Validation in Parkinson's D
54%
related
🧫
Axonal Transport Dysfunction Validation in Parkinson's
54%
related
🧫
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
54%
related
🧫
Alpha-Synuclein Seed Amplification Assay Validation
54%
related
🧫
Peroxisomal Dysfunction Validation in Parkinson's Disea
54%
related
🧫
Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me
54%
related
🧫
Parkinson's Disease Subtype Classification — Precision
54%
related
🧫
cGAS-STING Pathway Validation Study in Parkinson's Dise
54%
related
🧫
Ferroptosis Validation in Parkinson's Disease
54%
related
🧫
DNA Damage Repair Deficiency Validation Study in Parkinson
54%
related
🧫
Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in
54%
related
🧫
Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr
54%
related
🧫
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson
54%
related
🧫
Experiment: Multi-Ethnic PD GWAS
54%
related
🧫
Exercise-BDNF-Mitophagy Biomarker Study in PD
54%
related
🧫
NLRP3 Inflammasome Validation Study in Parkinson's Dise
54%
related
🧫
Antiviral Therapy Trial for Parkinson's Disease
54%
related
🧫
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
54%
related
🧫
Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
54%
related
🧫
Combination Therapy Sequencing in Parkinson's Disease
54%
related
🧫
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
54%
related
🧫
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
54%
related
🧫
Computational Modeling of Alpha-Synuclein Propagation in PD
54%
related
🧫
Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper
54%
related
🧫
Non-Motor Symptom Progression in Parkinson's Disease —
54%
related
🧫
Synaptic Vesicle Trafficking Dysfunction Validation in Parki
54%
related
🧫
Neural Oscillation Dysfunction Validation in Parkinson'
54%
related
🧫
Regulated Necrosis Validation Study in Parkinson's Dise
54%
related
🧫
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
54%
related
🧫
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
54%
related
🧫
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&
54%
related
🧫
Purinergic Signaling Dysfunction Validation in Parkinson
54%
related
🧫
Stress Granule Dysfunction Validation in Parkinson's Di
54%
related
🧫
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
54%
related
🧫
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&
54%
related
🧫
TREM2 Agonist Therapy for Parkinson's Disease — Experim
54%
related
🧫
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
54%
related
🧫
Macroautophagy Dysfunction in PD - Experiment Design
54%
related
🧫
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
54%
related
🧫
Validation: Membrane-Nucleation in iPSC Neurons
54%
related
🧫
AAV-LRRK2 IND-Enabling Study Design
54%
related
🧫
Sirtuin Dysfunction Validation in Parkinson's Disease
54%
related
🧫
Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
54%
related
🧫
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
54%
related
🧫
Validate Mitochondria-Lysosome Contact Site Dysfunction in P
54%
related
🧫
AAV Serotype Comparison for LRRK2 Knockdown in PD
54%
related
🧫
MLCS Quantification in Parkinson's Disease
54%
related
🧫
Cytochrome Therapeutics
54%
related
🧫
CRISPR Gene Correction Approaches for CBS/PSP
54%
related
🧫
Synaptic Mitochondrial Resilience Enhancement for Parkinson&
54%
related
🧫
Prodromal Parkinson's Disease Biomarker Development — E
54%
related
🧫
Peroxisome Dysfunction Validation in Parkinson's Diseas
54%
related
🧫
Endocannabinoid System Dysfunction Validation in Parkinson
54%
related
🧫
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
54%
related
🧫
Multiscale Computational Modeling of Protein Aggregation Kin
54%
related
🧫
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
54%
related
🧫
Epigenetic Dysregulation Validation in Parkinson's Dise
54%
related
🧫
GLP-1 Agonist Neuroprotection Mechanism in PD
54%
related
🔬
What cell types are most vulnerable in Alzheimer's Dise
50%
related
🔬
What are the mechanisms underlying blood-brain barrier trans
50%
related
🔬
What are the mechanisms underlying mitochondrial transfer be
50%
related
🔬
The disease-associated microglia (DAM) phenotype involves TR
50%
related
🔬
Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph
50%
related
🔬
What are the mechanisms underlying selective vulnerability o
50%
mentions
🧪
Quantum Coherence Disruption in Cellular Communication
50%
related
🔬
Is disrupted sleep a cause or consequence of neurodegenerati
50%
mentions
🧪
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
50%
related
🔬
What are the mechanisms underlying selective vulnerability o
50%
related
🔬
The disease-associated microglia (DAM) phenotype involves TR
50%
related
🔬
What cell types are most vulnerable in Alzheimers Disease ba
50%
mentions
🧪
Senescent Cell Mitochondrial DNA Release
50%
related
🔬
What are the mechanisms underlying mitochondrial transfer be
50%
related
🔬
What are the mechanisms underlying what are the mechanisms b
50%
related
🔬
What are the mechanisms underlying senolytic therapy for age
50%
related
🔬
Can gut-brain axis modulation prevent or slow Alzheimer'
50%
related
🔬
What are the mechanisms underlying what are the mechanisms b
50%
related
🔬
What are the mechanisms underlying senolytic therapy for age
50%
related
🔬
How to break the GBA-alpha-synuclein bidirectional loop for
50%
related
🔬
Mitochondrial transfer between astrocytes and neurons
50%
related
🔬
What are the mechanisms underlying blood-brain barrier trans
50%
related
🔬
What are the mechanisms underlying what are the mechanisms b
50%
related
🔬
Is disrupted sleep a cause or consequence of neurodegenerati
50%
mentions
🧪
Synthetic Biology BBB Endothelial Cell Reprogramming
50%
related
🔬
Why do entorhinal cortex layer II stellate neurons die first
50%
related
🔬
Epigenetic reprogramming in aging neurons
50%
mentions
🧪
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
50%
related
🔬
Comprehensive analysis of immune cell subtypes in neurodegen
50%
mentions
🧪
Enteric Nervous System Prion-Like Propagation Blockade
50%
related
🔬
What are the most promising therapeutic strategies for targe
50%
mentions
🧪
Extracellular Matrix Stiffness Modulation
50%
mentions
🔬
Is disrupted sleep a cause or consequence of neurodegenerati
40%
mentions
🔬
Comprehensive analysis of immune cell subtypes in neurodegen
40%
mentions
🔬
Why do entorhinal cortex layer II stellate neurons die first
40%
related
🧪
Senescent Cell Mitochondrial DNA Release
40%
mentions
🔬
What cell types are most vulnerable in Alzheimer's Dise
40%
mentions
🔬
Epigenetic reprogramming in aging neurons
40%
related
🧪
Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
40%
mentions
🔬
The disease-associated microglia (DAM) phenotype involves TR
40%
related
🧪
Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener
40%
mentions
🔬
What are the most promising therapeutic strategies for targe
40%
mentions
🔬
What are the mechanisms underlying what are the mechanisms b
40%
related
🧪
Synthetic Biology BBB Endothelial Cell Reprogramming
40%
mentions
🔬
Is disrupted sleep a cause or consequence of neurodegenerati
40%
mentions
🔬
Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph
40%
mentions
🔬
What are the mechanisms underlying mitochondrial transfer be
40%
mentions
🔬
What cell types are most vulnerable in Alzheimers Disease ba
40%
mentions
🔬
How to break the GBA-alpha-synuclein bidirectional loop for
40%
mentions
🔬
What are the mechanisms underlying mitochondrial transfer be
40%
mentions
🔬
What are the mechanisms underlying selective vulnerability o
40%
related
🧪
Enteric Nervous System Prion-Like Propagation Blockade
40%
mentions
🔬
What are the mechanisms underlying what are the mechanisms b
40%
mentions
🔬
The disease-associated microglia (DAM) phenotype involves TR
40%
mentions
🔬
Can gut-brain axis modulation prevent or slow Alzheimer'
40%
related
🔬
What are the mechanisms underlying microglia-astrocyte cross
40%
mentions
🔬
Mitochondrial transfer between astrocytes and neurons
40%
related
🧪
Age-Dependent Complement C4b Upregulation Drives Synaptic Vu
35%
related
🧪
Enteric Nervous System Prion-Like Propagation Blockade
35%
related
🧪
Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
35%
related
🔬
What gene expression changes in the aging mouse brain predic
27%
💬 Discussion
Show Comments
Loading comments...